IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
IRADIMED Corporation (IRMD), a Delaware corporation, filed this Current Report on Form 8-K on January 10, 2025. The filing announces the issuance of a press release containing preliminary unaudited revenue results for the fourth quarter and full year ended December 31, 2024.
Key Financial Metrics
The filing text references the announcement of preliminary unaudited revenues for Q4 2024 and full-year 2024 but does not disclose specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within the body of this document. These figures are contained in the attached press release (Exhibit 99.1), which is not included in the provided text.
Material Changes
No specific material changes versus prior periods are quantified in this filing text. The document serves solely as a notification that the company has released preliminary financial results.
Guidance, Outlook, and Risks
The filing includes standard legal disclaimers stating that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated. No specific forward-looking guidance, management commentary, or risk factors are detailed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 10, 2025) for the specific preliminary revenue figures for Q4 and full-year 2024.
- Verify the company's official website or investor relations portal for the full text of the press release referenced in this filing.
- Confirm whether the preliminary revenue figures align with prior analyst expectations or guidance.
- Check for any subsequent filings that may provide audited results or updated guidance.